Fred R. Hirsch(@fred_hirsch) 's Twitter Profileg
Fred R. Hirsch

@fred_hirsch

I am Executive Director at the Center for Thoracic Oncology at Mount Sinai Hospital , NYC and Professor of Medicine at Icahn Medical School at Mount Sinai, NY

ID:2827663376

linkhttp://www.mountsinai.org calendar_today23-09-2014 08:19:14

714 Tweets

3,3K Followers

61 Following

Follow People
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

Great discussion about future trial designs to figure out what the components in the perioperative setting contribute per se!

Great discussion about future trial designs to figure out what the components in the perioperative setting contribute per se!
account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

We need more prospective bio marker studies, particularly to study the role of ct DNA MRD. Tic Tac Toe study is interesting !

We need more prospective bio marker studies, particularly to study the role of ct DNA MRD. Tic Tac Toe study is interesting !
account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

This morning opening of AACR - FDA workshop of treatment of early stage solid cancers. Honored to be a panelist !

This morning opening of AACR - FDA workshop of treatment of early stage solid cancers. Honored to be a panelist !
account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

Great presentation by my colleague Dr. Rolfo discussing the role of liquid biopsy for prediction of response to immunotherapy !

Great presentation by my colleague Dr. Rolfo discussing the role of liquid biopsy for prediction of response to immunotherapy !
account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

Who could dream of these long-term survival data for advanced NSCLC 10 years ago! Great presentations in Rome!

Who could dream of these long-term survival data for advanced NSCLC 10 years ago! Great presentations in Rome!
account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Dr. Tina Cascone at gives a brilliant perspective on neoadjuvant vs adjuvant immunotherapy approaches. The neoadjuvant approach allows for tremendous translational study to inform the field. In clinic now, PDL1 informs likelihood of benefit.

Dr. Tina Cascone at #RomeLung24 gives a brilliant perspective on neoadjuvant vs adjuvant immunotherapy approaches. The neoadjuvant approach allows for tremendous translational study to inform the field. In clinic now, PDL1 informs likelihood of benefit.
account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

Great news this morning and congratulation to a esteemed colleague! Best wishes to Miriam, who does great scientific contributions in lung cancer.

Great news this morning and congratulation to a esteemed colleague! Best wishes to Miriam, who does great scientific contributions in lung cancer.
account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

Serum Detect Advancing T Cell Receptor Repertoire Platform for Lung Cancer Screening | 360Dx 360dx.com/molecular-diag…

account_circle
Fred R. Hirsch(@fred_hirsch) 's Twitter Profile Photo

Student Sooyun Caroline Tavolacci, MD, MSCR, Shares How Mount Sinai Inspired Her to Study Thoracic Oncology and Enhanced Her Career in Medicine health.mountsinai.org/blog/student-s… via Mount Sinai Health System

account_circle